Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 50% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price shot up 50% on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. 1,942,446 shares traded hands during mid-day trading, an increase of 1,795% from the average session volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Performance

The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market capitalization of C$14.64 million, a price-to-earnings ratio of -10.50 and a beta of 0.32. The firm’s fifty day moving average price is C$0.07 and its 200 day moving average price is C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.